The UC Davis Comprehensive Cancer Center has successfully renewed its Paul Calabresi K12 Clinical Oncology Career Development Award (PCACO). The award provides $3.98 million in funding from the National Cancer Institute (NCI) through 2026 to increase the number of clinicians-scientists trained in clinical and translational cancer research and to advance their career advancement as cancer researchers.
NCI started the program in 1991. In 1994, it was renamed the Paul Calabresi Award in Clinical Oncology in honor of the late Paul Calabresi, a pioneering oncologist who led the development of cancer drugs.
Scholars are selected through a rigorous process and are expected to develop their own investigator-initiated clinical trial during the training period.
The cancer center uses the program to train junior faculties (basic/translational scientists and clinical scientists) as researchers in team-based, patient-centered cancer research. Upon successful completion of a three-year, salary-supported core curriculum, scientists receive a UC Davis Comprehensive Cancer Center Certificate in Clinical Cancer Research.
“This is a high-impact program to train patient-centered cancer researchers early in their careers to become independent investigators,” said Primo “Lucky” Lara Jr., director of the UC Davis Comprehensive Cancer Center, who is also the principal investigator and program director of PCACO. . .
Selected scientists will receive 75% protected time for research, formal mentor training in clinical cancer research, $100,000 per year (for up to 3 years) in support of salary and benefits, and $13,000 per year (for up to 3 years) for research and travel expenses.
The supervised research training plan will be supervised by two senior, independently funded faculty members (a basic/translational mentor and a clinical mentor) who will guide the scholar in the development and execution of his/her research project.
UC Davis Comprehensive Cancer Center
UC Davis Comprehensive Cancer Center is the only National Cancer Institute-designated center serving the Central Valley and inland Northern California, a region of more than 6 million people. The specialists provide compassionate, comprehensive care to more than 15,000 adults and children each year and have access to more than 150 active clinical trials at any time. The innovative research program includes more than 225 UC Davis scientists working together to advance the discovery of new tools for cancer diagnosis and treatment. Patients have access to advanced care, including immunotherapy and other targeted treatments. The Office of Community Outreach and Engagement addresses the disparities in cancer outcomes across populations, and the cancer center provides comprehensive education and staffing programs for the next generation of clinicians and scientists. For more information, visit cancer.ucdavis.edu.